Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept

PURPOSE: Conbercept (KH902), a novel recombinant, soluble vascular endothelial growth factor (VEGF) receptor–IgG fusion protein, has been developed as a new drug for ocular neovascularization and macular edema. The present study aims to clarify the changes in conbercept levels, VEGF, and intraocular...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Liping, Peng, Hui, Wu, Quan, Zhu, Meidong, Luo, Delun, Ke, Xiao, Yang, Peizeng, Lei, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337358/
https://www.ncbi.nlm.nih.gov/pubmed/25737631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337358/
https://www.ncbi.nlm.nih.gov/pubmed/25737631

Ejemplares similares